SRX sierra rutile holdings limited

Sirtex in Bayer’s sights

  1. 8,918 Posts.
    lightbulb Created with Sketch. 32
    'Medical device maker Sirtex could be back on the radar of Bayer, with fresh talk in the market that the global medical research giant is weighing a takeover bid for the $1.6 billion company.
    Bayer has Sirtex in its sights because of the radioactive treatment it has developed for inoperable liver cancer called SIR-Spheres microspheres.'
    etc etc.
    http://www.theaustralian.com.au/bus...in-bayers-sights/story-fnjw8txa-1227358173716
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.